TickerFacts.

Bioxytran, Inc (BIXT): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

108.15M
As of 2025-12-31
114.70M
As of 2026-06-30
-4.3%
3-year compound annual growth
+2.1%
5-year compound annual growth
161.30M2010-12-31: 34.42M2011-12-31: 113.94M2012-12-31: 161.30M2013-12-31: 3.88M2014-12-31: 5.82M2015-12-31: 12.32M2016-12-31: 28.17M2017-12-31: 85.10M2018-12-31: 85.10M2019-12-31: 86.48M2020-12-31: 97.45M2021-12-31: 110.84M2022-12-31: 123.35M2023-12-31: 144.64M2024-12-31: 86.78M2025-12-31: 108.15M108.15M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31108.15M+24.6%2026-04-15, Balance as of period end
2024-12-3186.78M-40.0%2026-04-15, Balance as of period end
2023-12-31144.64M+17.3%2025-04-03, Balance as of period end
2022-12-31123.35M+11.3%2025-01-13, Balance as of period end
2021-12-31110.84M+13.7%2023-03-31, Balance as of period end
2020-12-3197.45M+12.7%2022-04-11, Balance as of period end
2019-12-3186.48M+1.6%2021-04-09, Balance as of period end
2018-12-3185.10M0.0%2020-03-18, Balance as of period end
2017-12-3185.10Mn/c2019-03-13, Balance as of period end
2016-12-3128.17M+128.7%2018-04-02, Balance as of period end
2015-12-3112.32M+111.8%2017-03-31, Balance as of period end
2014-12-315.82Mn/c2016-09-20, Balance as of period end
2013-12-313.88M-97.6%2015-04-10, Balance as of period end
2012-12-31161.30M+41.6%2014-04-14, Balance as of period end
2011-12-31113.94M+231.0%2013-04-15, Balance as of period end
2010-12-3134.42Mn/a2012-12-31, Balance as of period end